BEIJING ENT Restructures Board: New Governance, Compliance and Sustainability Committees Established

Bulletin Express
04/28

BEIJING ENT (Beijing Enterprises Holdings Limited) announced a comprehensive overhaul of its board committee structure, effective 28 April 2026, aimed at strengthening corporate governance, strategic oversight and ESG management.

Key changes and additions:

1. Nomination Committee upgraded • Renamed “Nomination and Governance Committee” to reflect an expanded mandate that now covers board effectiveness, director independence and overall governance framework. • Composition unchanged: Executive Director Yang Zhichang (chairman) and Independent Non-Executive Directors (INEDs) Dr. Yu Sun Say and Chan Man Ki Maggie.

2. Investment Committee broadened • Renamed “Strategy and Investment Committee,” adding responsibility for medium- to long-term strategic planning. • Membership expanded to five directors. Executive Director Xiong Bin becomes chairman, joined by Executive Directors Xu Tong and Tung Woon Cheung Eric, and INEDs Lam Hoi Ham and Chan Man Ki Maggie. Yang Zhichang steps down from this committee.

3. New Rule of Law and Compliance Committee • Five-member body led by Executive Director Xiong Bin. Other members: Executive Directors Geng Chao and Tung Woon Cheung Eric, Non-Executive Director (NED) Su Junjie and INED Chan Man Ki Maggie. • Charged with guiding and monitoring legal compliance and risk prevention across the group.

4. New Sustainability Committee • Chaired by Executive Director Xiong Bin; members include Executive Director Tung Woon Cheung Eric, NEDs Yu Xijian and Su Junjie, and INED Wu Jiesi. • Tasked with steering ESG strategy, overseeing sustainability risk management and ensuring alignment with Hong Kong Stock Exchange ESG disclosure requirements.

5. Remuneration Committee adjustment • Executive Director Xiong Bin joins as a member, replacing Yang Zhichang. • Committee now comprises Xiong Bin (Executive Director) and INEDs Wu Jiesi (chairman) and Lam Hoi Ham, maintaining an INED majority in line with Listing Rule 3.25.

Following these updates, the board still consists of 11 directors: five executive, two non-executive and four independent non-executive members.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10